HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Switch from conventional to every other day hemodialysis: a comparison pilot study.

Abstract
Fluid and solute fluctuations during the week are the main drawbacks of conventional hemodialysis (cHD) in patients' outcomes. The aim of our study was to evaluate the influence of every other day hemodialysis (eodHD) on clinical and laboratory parameters and to compare to that of cHD. Eighteen patients on cHD were included in the study. Nine patients (group I) were randomly switched to eodHD, while the rest (group II) remained on their regular cHD. By the end of the study (12 months) we observed a reduction in body weight followed by a parallel reduction in predialysis mean blood pressure by 7 mm Hg in group I (p<0.05) and the number of antihypertensives. Moreover, a reduction in left ventricular mass and an increment of ejection fraction was observed in group I. Hemoglobin levels remained stable in both groups, but erythropoietin dose was reduced in eodHD group. Dialysis delivered dose (dpKt/V) was higher and urea rebound phenomenon was less in group I. Finally, an improvement in uremia related and postdialysis symptoms was observed in the same group of patients. Our results showed that eodHD improved patients' clinical and biochemical status and therefore might have advantages in patients' outcomes compared with cHD.
AuthorsKonstantinos P Katopodis, Evangelia Dounousi, Anna Challa, Kostas Pappas, Rigas Kalaitzidis, Kostas C Siamopoulos
JournalASAIO journal (American Society for Artificial Internal Organs : 1992) (ASAIO J) 2009 Jan-Feb Vol. 55 Issue 1 Pg. 41-6 ISSN: 1538-943X [Electronic] United States
PMID19092650 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Recombinant Proteins
  • Erythropoietin
Topics
  • Blood Pressure (physiology)
  • Body Weight (physiology)
  • Erythropoietin (therapeutic use)
  • Female
  • Humans
  • Kidney Failure, Chronic (complications, therapy)
  • Male
  • Middle Aged
  • Pilot Projects
  • Recombinant Proteins
  • Renal Dialysis (methods)
  • Stroke Volume (physiology)
  • Uremia (etiology)
  • Ventricular Function, Left (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: